Kanamycin
Kanamycin
Kanamycin (pronounced: kah-nuh-MY-sin) is an aminoglycoside antibiotic introduced in the 1950s. It is produced by the bacterium Streptomyces kanamyceticus and is used to treat a wide variety of bacterial infections.
Etymology
The term "Kanamycin" is derived from Streptomyces kanamyceticus, the bacterium from which it was first isolated. The bacterium was named after Kanamycin, Japan, where it was discovered.
Usage
Kanamycin works by binding to the bacterial 30S ribosomal subunit, which inhibits protein synthesis and thus bacterial growth. It is used to treat a variety of infections, including tuberculosis, sepsis, and urinary tract infections.
Side Effects
Like other aminoglycosides, kanamycin can have serious side effects, including ototoxicity and nephrotoxicity. It can also cause allergic reactions in some patients.
Related Terms
- Aminoglycoside
- Antibiotic
- Bacterial Infections
- 30S ribosomal subunit
- Protein Synthesis
- Tuberculosis
- Sepsis
- Urinary Tract Infections
- Ototoxicity
- Nephrotoxicity
- Allergic Reactions
External links
- Medical encyclopedia article on Kanamycin
- Wikipedia's article - Kanamycin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski